资讯

PipelineReview.com54 分钟
Diakonos Oncology Presents Promising Phase I Results of Dubodencel (DOC1021) for the ...
HOUSTON, TX, USA I June 2, 2025 I Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat ...